Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,270 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).

NCT03306394

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Chris O'Brien Lifehouse Oncology Camperdown, Australia
  • St Vincent's Hospital The Kinghorn Cancer Centre Darlinghurst, Australia
  • St Vincent's Hospital (Melbourne) Cancer Centre Fitzroy, Australia
  • The Canberra Hospital Cancer,Ambulatory & Community Health Service (CACHS) Bldg 19 Garran, Australia
View all 99 locations
View Trial Details
Completed

Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer

NCT05702424

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Carolina Biooncology Institute Huntersville, North Carolina, United States
  • Oklahoma University Norman, Oklahoma, United States
View Trial Details
Completed

ER Reactivation Therapy for Breast Cancer

NCT02188745

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +8 more
Locations
  • Baystate Medical Center Springfield, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

NCT01231347

Conditions
Adenocarcinoma of the Pancreas, Advanced Malignancy, Advanced Solid Tumors, +29 more
Locations
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 152 locations
View Trial Details
Completed

99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer

NCT04233476

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Completed

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

NCT04641871

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

NCT01326871

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +20 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UF Health Center at Orlando Health Orlando, Florida, United States
  • Martin Health System Stuart, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 16 locations
View Trial Details

Related conditions